15.04
0.03 (0.20%)
Penutupan Terdahulu | 15.01 |
Buka | 15.10 |
Jumlah Dagangan | 1,698,591 |
Purata Dagangan (3B) | 1,762,467 |
Modal Pasaran | 48,002,265,088 |
Harga / Pendapatan (P/E TTM) | 34.98 |
Harga / Pendapatan (P/E Ke hadapan) | 37.45 |
Harga / Jualan (P/S) | 1.53 |
Harga / Buku (P/B) | 0.930 |
Julat 52 Minggu | |
Tarikh Pendapatan | 8 May 2025 |
Hasil Dividen (DY TTM) | 1,266.49% |
Margin Keuntungan | 4.54% |
Margin Operasi (TTM) | 0.53% |
EPS Cair (TTM) | 0.450 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 3.00% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | -77.50% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 73.21% |
Nisbah Semasa (MRQ) | 1.31 |
Aliran Tunai Operasi (OCF TTM) | 1.11 T |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 756.41 B |
Pulangan Atas Aset (ROA TTM) | 2.51% |
Pulangan Atas Ekuiti (ROE TTM) | 2.94% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Drug Manufacturers - Specialty & Generic (US) | Menurun | Bercampur |
Drug Manufacturers - Specialty & Generic (Global) | Menurun | Bercampur | |
Stok | Takeda Pharmaceutical Company L | Bercampur | Bercampur |
AISkor Stockmoo
Konsensus Penganalisis | -2.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -3.5 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | 2.0 |
Purata | -0.88 |
Takeda Pharmaceutical is Japan’s largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company’s five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada. |
|
Sektor | Healthcare |
Industri | Drug Manufacturers - Specialty & Generic |
Gaya Pelaburan | Large Core |
% Dimiliki oleh Orang Dalam | 0.01% |
% Dimiliki oleh Institusi | 2.34% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Managed Asset Portfolios, Llc | 31 Dec 2024 | 1,417,448 |
Soleus Capital Management, L.P. | 31 Dec 2024 | 1,180,000 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Hasil Dividen (DY TTM) | 1,266.49% |
Purata Hasil Dividen 5T | 3.39% |
Nisbah Pembayaran | 140.03% |
Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
---|---|---|---|
30 Mar 2023 | 15 Mar 2023 | 10 Jul 2023 | 0.30996 Tunai |
29 Sep 2022 | 13 Sep 2022 | 12 Dec 2022 | 0.329553 Tunai |
30 Mar 2022 | 04 Mar 2022 | 11 Jul 2022 | 0.330062 Tunai |
29 Sep 2021 | - | 13 Dec 2021 | 0.396898 Tunai |
30 Mar 2021 | 15 Mar 2021 | 12 Jul 2021 | 0.406627 Tunai |
29 Sep 2020 | - | 11 Dec 2020 | 0.430533 Tunai |
30 Mar 2020 | - | 06 Jul 2020 | 0.419053 Tunai |
27 Sep 2019 | 09 Sep 2019 | 12 Dec 2019 | 0.411118 Tunai |
28 Mar 2019 | 16 Mar 2019 | 10 Jul 2019 | 0.417168 Tunai |
26 Sep 2018 | - | 13 Dec 2018 | 0.395501 Tunai |
27 Mar 2018 | - | 09 Jul 2018 | 0.40643 Tunai |
27 Sep 2017 | - | 11 Dec 2017 | 0.39946 Tunai |
29 Mar 2017 | - | 10 Jul 2017 | 0.39892 Tunai |
28 Sep 2016 | - | 12 Dec 2016 | 0.392415 Tunai |
29 Mar 2016 | - | 11 Jul 2016 | 0.43705 Tunai |
28 Sep 2015 | - | 11 Dec 2015 | 0.365323 Tunai |
27 Mar 2015 | - | 09 Jul 2015 | 0.365289 Tunai |
25 Sep 2014 | - | 11 Dec 2014 | 0.378342 Tunai |
26 Mar 2014 | - | 10 Jul 2014 | 0.443655 Tunai |
25 Sep 2013 | - | 12 Dec 2013 | 0.436978 Tunai |
26 Mar 2013 | - | 08 Jul 2013 | 0.457131 Tunai |
25 Sep 2012 | - | 13 Dec 2012 | 0.545983 Tunai |
27 Mar 2012 | - | 09 Jul 2012 | 0.563768 Tunai |
27 Sep 2011 | - | 12 Dec 2011 | 0.578629 Tunai |
28 Mar 2011 | - | 07 Jul 2011 | 0.555761 Tunai |
27 Sep 2010 | - | 13 Dec 2010 | 0.533229 Tunai |
Papar semua |
Hasil Dividen Tahunan
Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
---|---|---|---|
2023 | 0.310 | 1 | 2.17 |
2022 | 0.660 | 2 | 4.23 |
2021 | 0.804 | 2 | 5.90 |
2020 | 0.850 | 2 | 4.67 |
2019 | 0.828 | 2 | 4.20 |
2018 | 0.802 | 2 | 4.77 |
2017 | 0.798 | 2 | 2.81 |
2016 | 0.829 | 2 | 3.99 |
2015 | 0.731 | 2 | 2.92 |
2014 | 0.822 | 2 | 3.96 |
2013 | 0.894 | 2 | 3.88 |
2012 | 1.11 | 2 | 5.00 |
2011 | 1.13 | 2 | 5.15 |
2010 | 0.533 | 1 | 2.19 |
Papar semua |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |